---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-123962"
form_type: "8-K"
ticker: "BNBX"
cik: "0000744452"
company_name: "BNB PLUS CORP."
filed_at: "2023-12-06T23:59:59+00:00"
generated_at: "2026-06-07T17:34:59.783169+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# APDN receives Nasdaq bid price non-compliance notice; cure period ends May 29, 2024

## Summary
- Nasdaq notified APDN that its common stock bid price closed below $1.00 for 30 consecutive business days through Nov 30, 2023.
- Company has 180 calendar days, until May 29, 2024, to regain compliance by closing at $1.00 for at least 10 consecutive business days.
- If not cured, APDN may be eligible for a second 180-day period if it meets other listing standards and intends to cure via reverse stock split.
- APDN may consider a reverse stock split or other options to regain compliance with the minimum bid price rule.

## SEC filing metadata
- accession: 0001104659-23-123962
- form_type: 8-K
- ticker: BNBX
- cik: 0000744452
- company_name: BNB PLUS CORP.
- filed_at: 2023-12-06T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/744452/000110465923123962/0001104659-23-123962-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/744452/000110465923123962/tm2332138d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-123962
- JSON: https://secwatch.observer/filing/0001104659-23-123962.json
- Plain text: https://secwatch.observer/filing/0001104659-23-123962.txt

## Key facts
- Listing & Compliance Notices
  BNB PLUS CORP. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: December 1, 2023, Applied DNA Sciences, Inc. (the “Company”) received written notice (the “Notification Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement e
  evidence_url: https://www.sec.gov/Archives/edgar/data/744452/000110465923123962/0001104659-23-123962-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.